Old Web
English
Sign In
Acemap
>
Paper
>
180 Hematologic responses to flexible dosing of azacitidine in higher risk MDS/AML: 7 day therapy over an 8 day period
180 Hematologic responses to flexible dosing of azacitidine in higher risk MDS/AML: 7 day therapy over an 8 day period
2011
Rajat Kumar
Pamela Skrabek
Kristjan Paulson
Matthew D. Seftel
Donald S. Houston
David Szwajcer
P. Burns
B. Lozar
Venetia Bourrier
Sri Navaratnam
Keywords:
Cancer research
Dosing
Azacitidine
Biology
Oncology
Immunology
Internal medicine
flexible dosing
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]